pazopanib
Showing 1 - 25 of 147
Advanced Cancers, Solid Tumors Trial in Houston (Pazopanib, Everolimus)
Active, not recruiting
- Advanced Cancers
- Solid Tumors
- Pazopanib
- Everolimus
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 16, 2022
Renal Cell Carcinoma, Ovarian Carcinoma, Thyroid Carcinoma Trial in Groningen (Olaparib, Lenvatinib, Sunitinib)
Not yet recruiting
- Renal Cell Carcinoma
- +4 more
- Olaparib
- +4 more
-
Groningen, NetherlandsUniversity Medical Center Groningen
Jul 13, 2023
Refractory Solid Tumors Trial in Seoul (pazopanib)
Completed
- Refractory Solid Tumors
- pazopanib
-
Seoul, Korea, Republic ofSamsung Medical Center
Jun 13, 2022
Hereditary Hemorrhagic Telangiectasia, Epistaxis, Anemia Trial (Pazopanib, Placebo oral capsule)
Not yet recruiting
- Hereditary Hemorrhagic Telangiectasia
- +4 more
- Pazopanib
- Placebo oral capsule
- (no location specified)
Aug 17, 2022
Refractory Solid Tumors Trial in Seoul (pazopanib)
Completed
- Refractory Solid Tumors
- pazopanib
-
Seoul, Korea, Republic ofSamsung Medical Center
Jun 13, 2022
Glioblastoma Multiforme Trial in Nice (Pazopanib)
Active, not recruiting
- Glioblastoma Multiforme
- Pazopanib
-
Nice, Cedex 2, FranceCentre Antoine Lacassagne
Mar 3, 2022
Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in France (Pazopanib, HDM201)
Recruiting
- Advanced Soft-tissue Sarcoma
- Metastatic Soft-tissue Sarcoma
- Pazopanib
- HDM201
-
Bordeaux, France
- +4 more
May 5, 2022
Solitary Fibrous Tumor, Extraskeletal Myxoid Chondrosarcoma Trial in Spain (Pazopanib)
Active, not recruiting
- Solitary Fibrous Tumor
- Extraskeletal Myxoid Chondrosarcoma
- Pazopanib
-
Palma De Mallorca, Islas Baleares, Spain
- +6 more
Jan 31, 2022
Advanced Cancers Trial in Houston (Crizotinib (Xalkori), Pazopanib, Pemetrexed)
Terminated
- Advanced Cancers
- Crizotinib (Xalkori)
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 3, 2021
Renal Cell Carcinoma Trial in Ireland, Sweden (Pazopanib)
Completed
- Renal Cell Carcinoma
- Pazopanib
-
Dublin, Leinster, Ireland
- +8 more
Dec 22, 2021
Kidney Cancer Trial in Houston (Pazopanib, Temsirolimus, Quality of Life Assessment)
Completed
- Kidney Cancer
- Pazopanib
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 24, 2021
Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York
Recruiting
- Locally Advanced Leiomyosarcoma
- +5 more
- Olaparib
- +3 more
-
New York, New YorkColumbia University/Herbert Irving Cancer Center
Jan 4, 2023
Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Carcinoma Trial in United States (Pazopanib, Doxil)
Unspecified Adult Solid Tumor - Protocol Specific, Breast Cancer - Female Trial in New Brunswick (Pazopanib, Paclitaxel,
Active, not recruiting
- Unspecified Adult Solid Tumor - Protocol Specific
- Breast Cancer - Female
- Pazopanib
- +2 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Sep 20, 2021
Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Pazopanib,
Completed
- Renal Cell Carcinoma
- Clear-cell Metastatic Renal Cell Carcinoma
- Nivolumab
- +3 more
-
Duarte, California
- +13 more
Nov 30, 2021
Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor Trial in Portland, Seattle
Completed
- Adult Alveolar Soft Part Sarcoma
- +18 more
- Gemcitabine
- +5 more
-
Portland, Oregon
- +1 more
Sep 23, 2021
Carcinoma, Renal Cell Trial in China, Korea, Republic of, Taiwan (Pazopanib, Sunitinib)
Completed
- Carcinoma, Renal Cell
- Pazopanib
- Sunitinib
-
Guangzhou, Guangdong, China
- +20 more
Dec 6, 2021
Sarcoma, Stomach Tumors, Tumors Trial run by the NCI (Pazopanib, ARQ 197)
Completed
- Sarcoma
- +2 more
- Pazopanib
- ARQ 197
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 23, 2021
Germ Cell Tumors, Measurable Disease Trial in Milano (Pazopanib)
Completed
- Germ Cell Tumors
- Measurable Disease
- Pazopanib
-
Milano, Mi, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
May 12, 2021
Osteosarcoma, Metastatic Osteosarcoma Trial in United States (pazopanib)
Terminated
- Osteosarcoma
- Metastatic Osteosarcoma
- pazopanib
-
Duarte, California
- +3 more
Apr 8, 2021
Acute Myeloid Leukemia Trial in Münster (Pazopanib)
Completed
- Acute Myeloid Leukemia
- Pazopanib
-
Münster, GermanyUnviersity Hospital of Münster (UKM)
Apr 6, 2021
Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York
Not yet recruiting
- Locally Advanced Leiomyosarcoma
- +8 more
- Olaparib
- +3 more
- (no location specified)
Jul 6, 2022
Ovarian Tumors, Tumors, Ovarian, Ovarian Cancer Trial in United Kingdom (Pazopanib, Fosbretabulin)
Terminated
- Ovarian Neoplasms
- +2 more
- Pazopanib
- Fosbretabulin
-
Bath, United Kingdom
- +9 more
May 13, 2021